- Report
- March 2024
- 199 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- April 2024
- 197 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- November 2023
- 149 Pages
Global
From €2416EUR$2,499USD£2,075GBP
- Report
- March 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,446GBP
- Report
- October 2023
- 166 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Report
- October 2023
- 300 Pages
Global
From €4636EUR$4,795USD£3,982GBP
- Report
- October 2023
- 100 Pages
Africa
From €3669EUR$3,795USD£3,151GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1208EUR$1,250USD£1,038GBP
- Report
- March 2024
- 209 Pages
Global
€4829EUR$4,995USD£4,148GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- October 2023
- 189 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- January 2021
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- April 2023
- 117 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Drug Pipelines
- January 2022
- 200 Pages
Global
From €7251EUR$7,500USD£6,228GBP
- Report
- January 2022
- 60 Pages
Global
From €3819EUR$3,950USD£3,280GBP
- Report
- January 2022
- 60 Pages
Global
From €3819EUR$3,950USD£3,280GBP
- Report
- January 2022
- 200 Pages
Global
From €7251EUR$7,500USD£6,228GBP
- Drug Pipelines
- January 2019
- 40 Pages
Global
From €1450EUR$1,500USD£1,246GBP
Gastroparesis Drug is a type of drug used to treat gastroparesis, a condition in which the stomach muscles are weakened and unable to properly move food through the digestive system. These drugs are used to reduce symptoms such as nausea, vomiting, bloating, and abdominal pain. Commonly prescribed drugs for gastroparesis include metoclopramide, domperidone, and erythromycin. Other drugs, such as prokinetics, may also be used to help improve gastric emptying.
Gastroparesis Drug is a part of the larger Gastrointestinal Drugs market, which includes drugs used to treat a variety of gastrointestinal conditions. These drugs are used to reduce symptoms, improve digestion, and prevent further complications. Commonly prescribed drugs in this market include antacids, proton pump inhibitors, and laxatives.
Some companies in the Gastroparesis Drug market include Novartis, GlaxoSmithKline, Pfizer, and Takeda. Other companies, such as Allergan, Merck, and AstraZeneca, also produce drugs for the treatment of gastroparesis. Show Less Read more